Please note: AABB reserves the right to make updates to this program.
Tuesday, November 6, 2018
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 18EL-377 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Physicians, Technologists, Nurses, Managers/Supervisors, Laboratory Staff, Medical Directors, Students/Fellows, Residents
Teaching Level: Intermediate
Director: Barbee Whitaker, PhD, Senior Director, Research, AABB, Bethesda, MD
Moderator: Deanna Fang, Director Blood Bank, Mayo Clinic, Jacksonville, FL
Presenters: Jo Wiersum, MD, Transfusion and Transplantation Reactions in Patients (TRIP), Netherlands; Barbee Whitaker, PhD, Senior Director, Research, AABB, Bethesda, MD
After participating in this educational activity, participants should be able to:
- Explain what a Patient Safety Organization is and why it is able to protect hospital data.
- Describe the use of hemovigilance data to improve patient safety in the US.
- Describe the use of hemovigilance data to improve patient safety internationally.
This program will explore how hemovigilance data are used to improve transfusion patient safety in the US and in the Netherlands. Material will explain what a Patient Safety Organization (PSO) is and why AABB established its PSO in 2008. There will be a discussion of the CDC NHSN Hemovigilance Module and how data are reported and shared with the AABB PSO.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Dr. Whitaker is Senior Director of the Department of Research for AABB. She is also the Senior Director of the AABB Center for Patient Safety, which has been designated an official patient safety organization by the Agency for Healthcare Research and Quality of the Department of Health and Human Services. She is responsible for AABB’s hemovigilance activities in coordination with hospitals, blood centers and the federal government.
Dr. Jo Wiersum obtained her medical degree in Leiden in 1981 and went on to work in the UK and the Republic of Guinea (West Africa). Since 1996 she has worked as a donor physician for the Dutch blood supply organisation, Sanquin. In 2000 she completed specialty training in community medicine. Since 2002 when the Dutch national hemovigilance office TRIP started, she has been its national medical coordinator. TRIP stands for Transfusion and Transplantation Reactions in Patients because it also handles reports on tissue and cell vigilance. Jo has chaired of the International Society for Blood Transfusion haemovigilance working party since 2011. In 2013 she obtained a PhD in medicine on a thesis entitled Hemovigilance: is it making a difference to safety in the transfusion chain.